Stabilization notice

As announced in connection with the offering to acquire newly issued shares in the Company and the listing of the Company’s shares on Nasdaq Stockholm (the ”Offering”), Carnegie may, acting as Sole Global Coordinator, carry out transactions aimed at supporting the market price of the shares at levels above those which might otherwise prevail in the market.

Stabilization transactions may be undertaken on Nasdaq Stockholm, in the over-the-counter market or otherwise, at any time during the period starting on the first day of trading in the shares on Nasdaq Stockholm and ending no later than 30 calendar days thereafter. The Sole Global Coordinator is, however, not required to undertake any stabilization and there is no assurance that stabilization will be undertaken. Stabilization, if undertaken, may be discontinued at any time without prior notice. In no event will transactions be effected at levels above the price in the Offering.

The board of directors of the Company have granted the Sole Global Coordinator an over-allotment option which may be utilized in whole or in part for 30 days from the first date of trading in the Company’s shares on Nasdaq Stockholm, to sell up to 1,213,235 additional shares, corresponding to up to 15 percent of the total number of shares encompassed by the Offering, at a price corresponding to the price in the Offering, i.e. SEK 68, to cover any over-allotment in connection with the Offering.

Carnegie has, in its capacity as stabilization manager, notified that stabilization measures has been undertaken, in accordance with article 5(4) in the Market Abuse Regulation 596/2014, on Nasdaq Stockholm as specified below. The contact person at Carnegie is Magnus Andersson (tel +46 8 5886 8800). 

Stabilization information:
Issuer:	Q-linea AB (publ)
Securities:	Shares (SE0011527845)
Offering size:	8,088,235 shares
Over-allotment option:	1,213,235 shares
Offer price:	SEK 68
Ticker:	QLINEA
Stabilization manager:	Carnegie Investment Bank AB (publ)

Stabilization transactions:
Date	Quantity	Price (highest)	Price (lowest)	Price (volume weighted average)	Currency	Trading venue
2018-12-07	620,000	68.00	66.20	67.4507	SEK	Nasdaq Stockholm
2018-12–10	157,469	67.70	65.92	66.4585	SEK	Nasdaq Stockholm
2018-12–11	100,050	66.50	65.55	65.9013	SEK	Nasdaq Stockholm
2018-12–12	45,398	66.00	62.94	64.7485	SEK	Nasdaq Stockholm
2018-12–13	9,323	65.11	64.50	64.9323	SEK	Nasdaq Stockholm
2018-12–14	9,035	67.00	65.20	66.4460	SEK	Nasdaq Stockholm
2018-12–17	24,571	67.55	65.20	66.0225	SEK	Nasdaq Stockholm
2018-12–18	9,509	67.00	65.50	66.3926	SEK	Nasdaq Stockholm

For further information, please contact:
Anders Lundin, CFO and IR
E-mail: anders.lundin@qlinea.com
Phone: +46 706 00 15 20
www.qlinea.com

This information is information that Q-linea is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was submitted for publication, through the agency of the contact person set out below, at 19.30 CET on 18 December 2018. 

Important information
This announcement is not and does not form a part of any offer for sale of securities.

Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any offering in the United States or to conduct a public offering of securities in the United States.

The offering of securities referred to in this announcement has been made by means of a prospectus. This announcement is not a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus.